American Healthcare REIT, Inc. (AHR)
NYSE: AHR · Real-Time Price · USD
34.75
-0.18 (-0.52%)
At close: May 12, 2025, 4:00 PM
34.75
0.00 (0.00%)
After-hours: May 12, 2025, 7:00 PM EDT
American Healthcare REIT Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for American Healthcare REIT stock have an average target of 33.86, with a low estimate of 29 and a high estimate of 37. The average target predicts a decrease of -2.56% from the current stock price of 34.75.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for American Healthcare REIT stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 5 | 5 | 5 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Initiates $37 | Strong Buy | Initiates | $37 | +6.47% | Apr 28, 2025 |
| Keybanc | Keybanc | Buy Maintains $35 → $34 | Buy | Maintains | $35 → $34 | -2.16% | Mar 31, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $36 → $37 | Buy | Maintains | $36 → $37 | +6.47% | Mar 25, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $34 | Buy | Reiterates | $34 | -2.16% | Mar 19, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Maintains $30 → $35 | Buy | Maintains | $30 → $35 | +0.72% | Mar 4, 2025 |
Financial Forecast
Revenue This Year
2.23B
from 2.06B
Increased by 8.10%
Revenue Next Year
2.37B
from 2.23B
Increased by 6.36%
EPS This Year
0.37
from -0.29
EPS Next Year
0.56
from 0.37
Increased by 52.05%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.4B | 2.6B | 2.9B |
| Avg | 2.2B | 2.4B | 2.7B |
| Low | 2.1B | 2.1B | 2.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 16.8% | 18.6% | 21.6% |
| Avg | 8.1% | 6.4% | 14.3% |
| Low | 0.2% | -4.3% | 8.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.44 | 0.65 | 0.83 |
| Avg | 0.37 | 0.56 | 0.80 |
| Low | 0.26 | 0.47 | 0.77 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 76.6% | 48.0% |
| Avg | - | 52.1% | 42.3% |
| Low | - | 27.6% | 38.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.